. 2002 Jan;4(1):9–18. doi: 10.1038/sj.neo.7900194

Table 2.

Summary of Basal Antigen Expression in the Absence of Added Exogenous Steroid.

(A) Prostatic Cell Lines
Antibody	DU145	DAR17	DAR19	DZeo1	LNCaP	LNCaP-r
HMFG1	++ (het)	++ (het)	++ (het)	++ (het)	-	-
HMFG2	-^*	-^*	-^*	-^*	-	-
C595	++ (het)	++ (het)	++ (het)	++ (het)	-	-
SM3	-^*	-^*	-^*	-^*	-	-
AR	-	++	++	-	++	+
LE61	++	++	++	++	++	++
(B) Breast Cell Lines
Antibody	MDA-MB-231	BT20	T47D	MCF7	ZR-75-1	MDA-MB-453
HMFG1	++ (het)	++	++	++	++	+
HMFG2	±	+	+	+	+	±
C595	++ (het)	++	++	++	++	+
SM3	+ (het)	++	+	+	++	±
AR	-	-	+	-	++	++
LE61	++	++	++	++	++	++

(A) Cell lines derived from PC. (B) Cell lines derived from breast cancer. (++/-) Give a guide as to comparative intensity of immunostaining. (het): heterogeneous expression.

Heterogeneous weak immunofluorescence seen with HMFG2 and SM3 at 10 times higher concentration (1:1).